IBEX Technologies Inc.

IBXNFOTCHealthcare

$1.00

$-0.07(-6.54%)

Market Cap$25270800

P/E Ratio—

52W High$1.1

52W Low$0.56

Avg Volume2K

Open$1.00

Beta-0.04

PE Ratio Market Cap Forecast

IBEX Technologies Inc. (IBXNF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

ibxnf · pe ratio · data through Jul 31, 2023

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for IBEX Technologies Inc. (IBXNF) measures how much investors pay for each dollar of the company's trailing earnings. IBXNF's current PE ratio of 9.23x is calculated by dividing its stock price of $1.00 by its TTM earnings per share of $0.16. +58.0% elevated vs 5Y avg 5.8x

9.23x

P/E Ratio (TTM)+58.0%

Source: FMP · /ratios-ttm · /analyst-estimates · 2023-07-31

Forward P/E

N/A

—

EPS (TTM)

$0.16

TTM · diluted EPS

PEG Ratio

0.05

Below 1.0 · Growth adjusted

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · IBEX Technologies Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2004 – 2023 · Annual

PE Ratio (TTM)

5Y Avg 5.8x

EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

Historical PE Range

Past 13 fiscal years · Front-end computed

Average

24.7x

13-yr mean

Median

9.2x

13-yr midpoint

Minimum

1.9x

Lowest year

Maximum

116.0x

Highest year

9.2x ← Now

1.9x
MinQ1 · 25%9.2x
MedianQ3 · 75%116.0x
Max

Within Historical Range

At 9.23x, IBXNF's current P/E is within its average historical range over the past 13 fiscal years.

54th percentileHigher than 7 of 13 historical fiscal year readings

Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE

Company	Market Cap	PE (Annual)	vs Avg	EPS (TTM)
IBEX Technologies Inc.You IBXNF	$25M	9.23x	—	$0.16
OKYO Pharma Limited EMMLF	$23M	N/A	—	—
Generation Hemp, Inc. GENH	$25M	N/A	—	-$0.06
IntelGenx Technologies Corp. IGXT	$30M	N/A	—	-$0.06
ImmuPharma plc IMMPF	$28M	N/A	—	—
Kadimastem Ltd KMSTF	$10M	N/A	—	-$6.32
Mauna Kea Technologies S.A. MKEAF	$26M	N/A	—	-$0.16

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years

Fiscal Year End	PE Ratio	EPS (TTM)	YoY Change
2023-07-31Latest FY2023	6.80x	$0.16	+48.9%
2022-07-31 FY2022	4.57x	$0.07	-49.3%
2021-07-31 FY2021	9.01x	$0.03	+30.1%
2020-07-31 FY2020	6.93x	$0.04	—
2019-07-31 FY2019	—	$-0.05	—
2018-07-31 FY2018	—	$-0.00	—
2017-07-31 FY2017	1.91x	$0.12	-96.8%
2016-07-31 FY2016	59.25x	$0.00	+108.0%
2015-07-31 FY2015	28.48x	$0.01	—
2014-07-31 FY2014	—	$-0.02	—

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

PE Ratio = Stock Price ÷ EPS (TTM)

= $1.00 ÷ $0.16 = 9.23x

TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures

Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year

PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium

Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Price history Financial statements Earnings

Frequently asked questions

IBXNF pe ratio · 6 questions

IBXNF's current PE ratio is 9.23x as of 2026-06-09, based on a stock price of $1.00 and TTM EPS of $0.16. Data sourced from Financial Modeling Prep via IBXNF's SEC 10-K and 10-Q filings.

IBXNF PE ratioWhat is IBXNF PE ratioCurrent PE ratio of IBXNFIBXNF PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · IBEX Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09